118 related articles for article (PubMed ID: 24665587)
1. [Long effect of a booster on rubella antibodies from each original HI titer following vaccination].
Terada K; Akaike H; Ogita S; Ouchi K
Kansenshogaku Zasshi; 2014 Jan; 88(1):110-6. PubMed ID: 24665587
[TBL] [Abstract][Full Text] [Related]
2. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
[TBL] [Abstract][Full Text] [Related]
3. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
[TBL] [Abstract][Full Text] [Related]
4. [What EIA assay levels correspond to rubella antibody HI assay titer?].
Terada K; Inoue M; Wakabayashi T; Ogita S; Ouchi K
Kansenshogaku Zasshi; 2009 Jan; 83(1):26-30. PubMed ID: 19227221
[TBL] [Abstract][Full Text] [Related]
5. [Phases 3 and 4 immunization immunogenicity with combined measles-rubella vaccine].
Ozaki T; Nishimura N; Gotoh K; Ohe K; Funahashi K; Maeda K; Okuno Y
Kansenshogaku Zasshi; 2011 May; 85(3):250-5. PubMed ID: 21706844
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of measles-rubella vaccination for mothers in early puerperal phase.
Hisano M; Kato T; Inoue E; Sago H; Yamaguchi K
Vaccine; 2016 Feb; 34(9):1208-14. PubMed ID: 26801065
[TBL] [Abstract][Full Text] [Related]
7. Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults.
McLean HQ; Fiebelkorn AP; Ogee-Nwankwo A; Hao L; Coleman LA; Adebayo A; Icenogle JP
Vaccine; 2018 Sep; 36(38):5732-5737. PubMed ID: 30107992
[TBL] [Abstract][Full Text] [Related]
8. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
Seagle EE; Bednarczyk RA; Hill T; Fiebelkorn AP; Hickman CJ; Icenogle JP; Belongia EA; McLean HQ
Vaccine; 2018 Feb; 36(6):818-826. PubMed ID: 29317117
[TBL] [Abstract][Full Text] [Related]
9. Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women.
Hanaoka M; Hisano M; Watanabe N; Sugawara K; Kambe Y; Kanda E; Sago H; Kato T; Yamaguchi K
Vaccine; 2013 May; 31(19):2343-7. PubMed ID: 23523405
[TBL] [Abstract][Full Text] [Related]
10. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
[No Abstract] [Full Text] [Related]
11. Measles immunity and response to revaccination of a young adult population in Israel.
Mendelson E; Duvdevani P; Varsano N; Lerman Y; Slepon R; Dagan R; Cohen D; Danon Y; Shohat T
J Med Virol; 1996 Nov; 50(3):249-53. PubMed ID: 8923290
[TBL] [Abstract][Full Text] [Related]
12. [EIA-IgG antibody measles prevention level estimated from measles neutralizing, particle agglutination and hemagglutination-inhibition antibody titer].
Takayama N; Saika S; Ichinohe S
Kansenshogaku Zasshi; 2009 Sep; 83(5):519-24. PubMed ID: 19860253
[TBL] [Abstract][Full Text] [Related]
13. [Gelatin particle agglutination (PA) antibody: comparison to neutralizing antibody (NT) and hemagglutination inhibition (HI) antibody and relationship to IgG avidity].
Saika S; Matsunaga T; Ogawa T; Ichinohe S
Kansenshogaku Zasshi; 2008 Jul; 82(4):310-6. PubMed ID: 18697482
[TBL] [Abstract][Full Text] [Related]
14. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens.
Nilsson A; De Milito A; Engström P; Nordin M; Narita M; Grillner L; Chiodi F; Björk O
Pediatrics; 2002 Jun; 109(6):e91. PubMed ID: 12042585
[TBL] [Abstract][Full Text] [Related]
15. [Safety and efficacy in two-dose vaccination using measles and rubella combined (MR) vaccine].
Terada K; Ouchi K; Ihara T; Okada K; Numazaki K
Kansenshogaku Zasshi; 2008 Sep; 82(5):414-8. PubMed ID: 18975583
[TBL] [Abstract][Full Text] [Related]
16. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A
Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235
[TBL] [Abstract][Full Text] [Related]
17. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
Kontio M; Palmu AA; Syrjänen RK; Lahdenkari M; Ruokokoski E; Davidkin I; Vaarala O; Melin M
J Infect Dis; 2016 Jun; 213(12):2005-13. PubMed ID: 26908733
[TBL] [Abstract][Full Text] [Related]
18. [Vaccination against rubella, measles, chickenpox, and mumps in nursing students].
Tashiro T; Urata H; Okada J; Iwanaga K; Tokunaga M; Matsumoto T
Kansenshogaku Zasshi; 2004 May; 78(5):398-403. PubMed ID: 15211861
[TBL] [Abstract][Full Text] [Related]
19. Differences in levels of rubella hemagglutination inhibition antibody titers according to birth cohort.
Kaneko M; Ichida M; Fujii Y; Noda S; Ohi M
J Infect Chemother; 2021 Mar; 27(3):434-438. PubMed ID: 33077365
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of medical students to vaccine-preventable viral diseases: a serological study.
Kukino J; Naito T; Mitsuhashi K; Oshima H; Sekiya S; Isonuma H; Watanabe K; Dambara T; Hayashida Y
J Infect Chemother; 2004 Dec; 10(6):335-7. PubMed ID: 15614457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
